Salta al contenuto principale

mevalonate kinase

L MVK gene provides instructions for making the mevalonate kinase enzyme. This enzyme converts a substance called mevalonic acid into mevalonate-5-phosphate. This conversion is the second step in a pathway that produces cholesterol. The cholesterol is later converted into steroid hormones and bile acids. Steroid hormones are needed for normal development and reproduction, and bile acids are used to digest fats. Mevalonate kinase also helps to produce other substances that are necessary for certain cellular functions, such as cell growth, cell maturation (differentiation), formation of the cell's structural framework (the cytoskeleton), gene activity (expression), and protein production and modification.

Scelte video per Genes
Video library

Normal function

L MVK gene provides instructions for making the mevalonate kinase enzyme. This enzyme converts a substance called mevalonic acid into mevalonate-5-phosphate. This conversion is the second step in a pathway that produces cholesterol. The cholesterol is later converted into steroid hormones and bile acids. Steroid hormones are needed for normal development and reproduction, and bile acids are used to digest fats. Mevalonate kinase also helps to produce other substances that are necessary for certain cellular functions, such as cell growth, cell maturation (differentiation), formation of the cell's structural framework (the cytoskeleton), gene activity (expression), and protein production and modification.

Conditions referring to this gene or chromosome

Altri nomi

KIME_HUMAN

LH receptor mRNA-binding protein

LRBP

mevalonate kinase 1

MK

MVLK

Related patient information and medicines

Distrofia muscolare

Patient information leaflet

Distrofia muscolare

Also, if a child has delayed motor milestones (as mentioned above), a doctor may advise testing for MD, even though the problem could be due to another cause. MD may be diagnosed using one or more of the following tests: A blood test Blood tests for creatine kinase (CK) - in many types of MD, the blood level of CK is very high. A muscle biopsy.

Disordini di accumulo di glicogeno

Patient information leaflet

Disordini di accumulo di glicogeno

Disordini di accumulo di glicogeno are a group of inherited diseases. They result from a problem with one of the proteins (known as enzymes) involved in the conversion of glucose to glycogen, or the breakdown of glycogen back into glucose. They mostly tend to affect your liver and muscles. Most are diagnosed in childhood. Symptoms include weakness,.

Cancro alla bocca

Patient information leaflet

Cancro alla bocca

Cancro alla bocca is also sometimes called oral cancer. Diagnosing mouth cancer Your healthcare professional may suspect mouth cancer if y... Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being.

distrofia muscolare di Duchenne

Patient information leaflet

distrofia muscolare di Duchenne

What causes Distrofia muscolare di Duchenne. distrofia muscolare di Duchenne is caused by a genetic change which affects the muscles. Muscles contain a protein called dystrophin, which is necess... This tests for creatine kinase. Children with DMD always have a very high level of la creatina chinasi (about 10-100 times normal). Therefore, if a child's.

Pompholyx

Patient information leaflet

Pompholyx

Its effectiveness for pompholyx is still being studied, so it is not recommended yet. Dapilumab : this medication is used for a type of eczema called atopic dermatitis. In some cases it has been shown to be helpful for the treatment of pompholyx. Janus Kinase (JAK) inhibitors : these medications, available as creams or pills, target specific.

Mielofibrosi

Patient information leaflet

Mielofibrosi

Mielofibrosi is a serious bone marrow disorder that disrupts your body's normal production of blood cells. ...ed by myelofibrosis is a mutation in Janus Kinase 2 (JAK2)Dr Sarah Jarvis, December 2021 NICE guidance on drug treatments for myelofibrosis Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis The National.

Storia dell'articolo

Le informazioni su questa pagina sono scritte e revisionate da clinici qualificati.
  • 18 Ago 2020 | Ultima versione
  • 1 Apr 2011 | Pubblicato originariamente

Partecipa alla conversazione

Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.

Avvertenza: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Farmacia online, trattamenti e servizi sanitari

Accesso semplice a trattamenti affidabili e servizi sanitari online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Iscriviti alla newsletter di Patient

La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.

Per favore, inserisci un indirizzo email valido

Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.